ZERENVIA, created in 2015 (United States), from
61 sister brands
and 17479 competing brands.
ZERENVIA is owned by Biogen Idec, listed on the stock exchange of New York
ZERENVIA is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.